Target intelligence / Profile preview

novel transcript, antisense to Polymerase I and transcript release factor

Molecular classification
long non-coding RNA, Other
01

Overview

ENSG00000294400 is a predicted non-coding transcript antisense to PTRF, lacking evidence for protein-coding function or validated therapeutic relevance. It is annotated as a non-coding RNA that is transcribed from a locus opposite to the Polymerase I and transcript release factor (PTRF/CAVIN1) gene. There is currently no evidence that this transcript encodes a protein or functions as a typical therapeutic target. Its biological function and role in disease—if any—remain unknown or uncharacterized. No interactions with drugs, known mechanism of action, biomarkers, or safety concerns are reported. This type of annotation typically arises from transcriptomics pipelines identifying non-coding RNAs or speculative transcripts, and such entries may be subject to change or removal as annotation databases are updated. It is not considered a validated or actionable biomedical target, and the entry may reflect a provisional, computationally predicted, or low-confidence transcript model. This entity is not synonymous with PTRF/CAVIN1; it is annotated as a "novel" antisense transcript, not the well-characterized PTRF gene itself. As it is neither a protein-coding gene nor a functionally validated non-coding RNA, it is not considered a therapeutic target.

Other names
ENSG00000294400antisense PTRF transcript
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on novel transcript, antisense to Polymerase I and transcript release factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to Polymerase I and transcript release factor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call